MAPT and Cognitive impairment: reported that the overexpression of LCMT1 desensitised Aβ’s impact on cognitive impairment in mice, a phenomenon that could be attributed to rescued downstream tau function, and the sensitised outcome in the PME1 overexpression model [183].